Aurobindo Pharma Limited, an India-based pharmaceutical company, announced the appointment of T. Vijaya Kumar as President – R&D (Specialty Drug Delivery), with effect from April 5, 2024. According to the company’s exchange filing, “Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company hereby inform that upon recommendation of…